Showing results (201-210 of 260) with videos related to
Sort By:
Pageof 26
Molecular Cancer Therapeutics|November 29, 2018
Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant MelanomasDavid Garandeau, Justine Noujarède, Justine Leclerc, et al.Journal of Clinical Immunology|February 10, 2012
Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapyCaroline Veuillen, Thérèse Aurran-Schleinitz, Rémy Castellano, et al.Frontiers in Immunology|January 27, 2025
CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AMLJulia Wlosik, Florence Orlanducci, Manon Richaud, et al.Cancer Research|October 3, 2012
ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cellsJulien Faget, Nathalie Bendriss-Vermare, Michael Gobert, et al.The Journal of Infectious Diseases|April 1, 2024
Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19Laetitia Gay, Marie-Sarah Rouviere, Soraya Mezouar, et al.Cancer|February 11, 2004
Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virusRégis T Costello, Hacène Zerazhi, Aude Charbonnier, et al.Experimental Hematology|October 11, 2003
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimenCatherine Faucher, Mohamad Mohty, Norbert Vey, et al.Clinical & Translational Immunology|August 10, 2017
NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147Françoise Gondois-Rey, Antoine Chéret, Samuel Granjeaud, et al.Cancer Research|June 2, 2016
Follicular B Lymphomas Generate Regulatory T Cells via the ICOS/ICOSL Pathway and Are Susceptible to Treatment by Anti-ICOS/ICOSL TherapyKieu-Suong Le, Marie-Laure Thibult, Sylvain Just-Landi, et al.Clinical & Translational Immunology|November 19, 2025
Immediate variations in high-dimensional circulating immune cells following pancreatectomyJonathan Garnier, Anaïs Palen, Xavier Durand, et al.Pageof 26